Not Signed In -
Stomach Cancer |
Gastric (Stomach) Cancer; Gastric Cancer; Stomach (Gastric) Cancer |
Stomach cancer (also called gastric cancer) can develop in any part of the stomach and may spread throughout the stomach and to other organs, particularly the esophagus, small intestine. It also may extend through the stomach wall and spread to nearby lymph nodes and to organs such as the liver, pancreas, and colon. Stomach cancer also may spread to distant organs, such as the lungs, the lymph nodes above the collar bone, and the ovaries. Metastasis to the ovary is called a Krukenberg tumor ...
Wikipedia - [full article]
Stomach Cancer Clinical Trials
- Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer
ClinicalTrials.gov Identifier: NCT00201747 - Active, not recruiting
Esophageal Cancer; Esophagus Cancer; Cancer of Stomach; Stomach Cancer
- Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00004099 - Active, not recruiting
stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer; intestinal adenocarcinoma of the stomach; ...
- Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer
ClinicalTrials.gov Identifier: NCT00103324 - Active, not recruiting
recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer; diffuse adenocarcinoma of the stomach; ...
- Selective COX-II Inhibitor as a Palliative Therapy in Patients With R1 or R2 Resection for Disseminated Stomach Cancer - A Multi-Centre Prospective Randomized Controlled Trial
ClinicalTrials.gov Identifier: NCT00165048 - Active, not recruiting
Cancer of Stomach
- Selective COX-II Inhibitor as an Adjuvant Therapy in Patients With Resectable Advanced Stomach Cancer ( Histological Staging ≥ T2N1) - A Multi-Centre Prospective Randomised Controlled Trial
ClinicalTrials.gov Identifier: NCT00164892 - Active, not recruiting
Cancer of Stomach
- Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer
ClinicalTrials.gov Identifier: NCT00103103 - Active, not recruiting
recurrent gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
- Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00002783 - Active, not recruiting
stage III gastric cancer; stage II gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
- Antineoplaston Therapy in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00003524 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
- Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach
ClinicalTrials.gov Identifier: NCT00075465 - Active, not recruiting
adenocarcinoma of the stomach; stage III gastric cancer; stage IV gastric cancer
- A Phase I Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00446290 - Recruiting
Stomach Cancer
- Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and GEJ
ClinicalTrials.gov Identifier: NCT00525785 - Recruiting
Stomach Cancer; Gastric Cancer
- Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00002615 - Active, not recruiting
stage II gastric cancer; stage III gastric cancer; adenocarcinoma of the stomach
- Neoadjuvant Irinotecan and Cisplatin Followed By Surgical Resection in Treating Patients With Locally Advanced Cancer of the Stomach or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00062374 - Active, not recruiting
adenocarcinoma of the stomach; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer
- CLASSIC - Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer
ClinicalTrials.gov Identifier: NCT00411229 - Recruiting
Stomach Neoplasms
- Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00054457 - Active, not recruiting
adenocarcinoma of the stomach; Adenocarcinoma of the Esophagus; stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; ...
- Assessing Quality of Life of Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00020826 - Active, not recruiting
adenocarcinoma of the stomach; Quality of Life
- An International Phase 2 Study Of Su011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy
ClinicalTrials.gov Identifier: NCT00226811 - Recruiting
Stomach Cancer
- Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach
ClinicalTrials.gov Identifier: NCT00061932 - Recruiting
adenocarcinoma of the stomach; recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer
- Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach
ClinicalTrials.gov Identifier: NCT00020761 - Active, not recruiting
stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; recurrent esophageal cancer; adenocarcinoma of the stomach; ...
- Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov Identifier: NCT00074009 - Active, not recruiting
recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
- S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery For Locally Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00134095 - Recruiting
adenocarcinoma of the stomach; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer
- Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
ClinicalTrials.gov Identifier: NCT00005607 - Active, not recruiting
stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
- Omeprazole and Amoxicillin and/or Vitamin and Mineral Supplements and/or Garlic Supplements in Preventing Stomach Cancer in Patients With Precancerous Stomach Lesions
ClinicalTrials.gov Identifier: NCT00134121 - Active, not recruiting
Gastric Cancer; Precancerous Condition
- Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00020787 - Active, not recruiting
stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
- Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00002883 - Active, not recruiting
stage I gastric cancer; stage II gastric cancer; stage I esophageal cancer; stage II esophageal cancer; adenocarcinoma of the stomach; ...
- Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery
ClinicalTrials.gov Identifier: NCT00005876 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; ...
- Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
ClinicalTrials.gov Identifier: NCT00084604 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
- Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer
ClinicalTrials.gov Identifier: NCT00003298 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer; stage II gastric cancer; adenocarcinoma of the stomach
- Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00012363 - Active, not recruiting
stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; recurrent esophageal cancer; adenocarcinoma of the stomach; ...
- Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00006038 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; stage IV gastric cancer; ...
- Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00004236 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; ...
- Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer
ClinicalTrials.gov Identifier: NCT00006081 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; stage IV gastric cancer; ...
- BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy
ClinicalTrials.gov Identifier: NCT00017043 - Active, not recruiting
stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
- Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer
ClinicalTrials.gov Identifier: NCT00042510 - Active, not recruiting
Stomach Neoplasms; Esophageal Neoplasms
- Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach
ClinicalTrials.gov Identifier: NCT00003237 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; stage II esophageal cancer; ...
- Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00022139 - Active, not recruiting
stage III gastric cancer; stage II esophageal cancer; stage III esophageal cancer; adenocarcinoma of the stomach; ...
- Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors
ClinicalTrials.gov Identifier: NCT00511576 - Recruiting
Breast Cancer; Lung Cancer; Pulmonary Cancer; Non-Small-Cell Lung Carcinoma; Prostate Cancer; Prostatic Cancer; Gastric Cancer; Stomach Cancer
- S-1 and Cisplatin or Fluorouracil and Cisplatin in Treating Patients With Locally Advanced or Metastatic Gastric Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00128609 - Recruiting
stage IV gastric cancer; recurrent gastric cancer; adenocarcinoma of the stomach
- Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer
ClinicalTrials.gov Identifier: NCT00524186 - Recruiting
Esophageal Cancer; Gastric Cancer
- ILF With/Without Cisplatin for Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00320294 - Active, not recruiting
Stomach Neoplasm
- Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers
ClinicalTrials.gov Identifier: NCT00291473 - Recruiting
Esophageal Cancer; Lung Cancer; Stomach Cancer; Breast Cancer; Ovarian Cancer
- Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00514020 - Recruiting
Gastric Cancer
- A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers.
ClinicalTrials.gov Identifier: NCT00177255 - Active, not recruiting
Cancer
- Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
ClinicalTrials.gov Identifier: NCT00040859 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00217581 - Recruiting
Esophageal Cancer; Gastric Cancer
- Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway
ClinicalTrials.gov Identifier: NCT00498134 - Active, not recruiting
Stomach Neoplasms
- High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00002722 - Active, not recruiting
childhood gastrointestinal cancer; stage III gastric cancer; stage IV gastric cancer
- Irinotecan in Treating Patients With Esophageal or Stomach Cancer
ClinicalTrials.gov Identifier: NCT00003748 - Active, not recruiting
stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; ...
- LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
ClinicalTrials.gov Identifier: NCT00010270 - Active, not recruiting
Colorectal Cancer; Esophageal Cancer; Gastric Cancer; Pancreatic Cancer
- S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer
ClinicalTrials.gov Identifier: NCT00088816 - Recruiting
stage IV gastric cancer; adenocarcinoma of the stomach
- Oblimersen, Cisplatin, and Fluorouracil in Treating Patients With Advanced Esophageal, Gastroesophageal Junction, or Stomach Cancer
ClinicalTrials.gov Identifier: NCT00064259 - Active, not recruiting
Esophageal Cancer; Gastric Cancer
- Identifying Genetic Markers for Esophageal Cancer and Stomach Cancer in Chinese Populations
ClinicalTrials.gov Identifier: NCT00558415 - Recruiting
Esophageal Cancer; Gastric Cancer
- Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
ClinicalTrials.gov Identifier: NCT00489515 - Recruiting
Colorectal Cancer; Gallbladder Cancer; Gastric Cancer; Pancreatic Cancer; Small Intestine Cancer
- Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00004873 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer; recurrent gastric cancer
- Metastatic Gastric Cancer FFCD 03-07
ClinicalTrials.gov Identifier: NCT00374036 - Recruiting
Stomach Cancer; Neoplasm Metastasis
- S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer
ClinicalTrials.gov Identifier: NCT00182611 - Recruiting
Gastric Cancer
- Trial of Adjuvant Chemotherapy for Gastric Cancer
ClinicalTrials.gov Identifier: NCT00296322 - Recruiting
Stomach Cancer
- Trial of Adjuvant Chemotherapy for Gastric Cancer
ClinicalTrials.gov Identifier: NCT00296335 - Recruiting
Stomach Cancer
- Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stomach Cancer That Can Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00335959 - Recruiting
Gastric Cancer
- Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Stomach Cancer
ClinicalTrials.gov Identifier: NCT00354224 - Recruiting
Gastric Cancer
- Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
ClinicalTrials.gov Identifier: NCT00394433 - Recruiting
Esophageal Cancer; Stomach Cancer
- Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas
ClinicalTrials.gov Identifier: NCT00419627 - Not yet recruiting
Colorectal Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Breast Neoplasms; Ovarian Cancer
- Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer
ClinicalTrials.gov Identifier: NCT00006389 - Active, not recruiting
stage III gastric cancer; stage IV gastric cancer
- Irinotecan in Treating Patients With Advanced Cancer of the Stomach
ClinicalTrials.gov Identifier: NCT00003137 - Completed
stage IV gastric cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; intestinal adenocarcinoma of the stomach; ...
- Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer
ClinicalTrials.gov Identifier: NCT00477880 - Recruiting
Gastric Cancer; Precancerous/Nonmalignant Condition
- Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach
ClinicalTrials.gov Identifier: NCT00004233 - Active, not recruiting
Gastric Cancer; Esophageal Cancer; Adenocarcinoma of the Esophagus
- An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00270543 - Not yet recruiting
Stomach Neoplasms
- Chlorambucil Compared With No Further Therapy Following Anti- Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
ClinicalTrials.gov Identifier: NCT00003617 - Active, not recruiting
stage I gastric cancer
- A Double-Blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium
ClinicalTrials.gov Identifier: NCT00125736 - Recruiting
Stomach Ulcer
- Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00004103 - Active, not recruiting
stage I gastric cancer; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer
- Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
ClinicalTrials.gov Identifier: NCT00010283 - Active, not recruiting
Leukemia; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; kidney tumor
- Imatinib Mesylate in Treating Patients With Refractory Metastatic and/or Unresectable Stomach or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00068380 - Active, not recruiting
recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; stage IV esophageal cancer; stage III esophageal cancer; ...
- Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer
ClinicalTrials.gov Identifier: NCT00005060 - Active, not recruiting
stage II gastric cancer; stage III gastric cancer
- Docetaxel and Oxaliplatin in Gastric Cancer
ClinicalTrials.gov Identifier: NCT00382720 - Recruiting
Stomach Neoplasms
- Optical Coherence Tomography of the Gastrointestinal Tract
ClinicalTrials.gov Identifier: NCT00579748 - Active, not recruiting
Barrett's Esophagus With or Without Dysplasia; Patients With Early Esophageal or Gastric Cancer; Patients With Intestinal Metaplasia of the Stomach
- Intraperitoneal Floxuridine in Gastric Carcinoma
ClinicalTrials.gov Identifier: NCT00058916 - Recruiting
Stomach Neoplasms
- Study of Adjuvant Radiochemotherapy for Gastric Cancer
ClinicalTrials.gov Identifier: NCT00188266 - Recruiting
Stomach Neoplasms
- Docetaxel and Epirubicin in Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00375999 - Recruiting
Stomach Neoplasms
- Role of Routine Nasogastric Decompression After Subtotal Gastrectomy
ClinicalTrials.gov Identifier: NCT00164918 - Recruiting
Cancer of Stomach
- Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer
ClinicalTrials.gov Identifier: NCT00420394 - Recruiting
Stomach Neoplasms
- Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00525005 - Recruiting
Stomach Neoplasms
- Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Previously Untreated Stomach Cancer or Gastroesophageal Junction Cancer That Can Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00450203 - Not yet recruiting
Gastric Cancer
- Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00384878 - Recruiting
Stomach Neoplasms
- Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00411151 - Recruiting
Adenocarcinoma of Stomach; Barret Esophagus
- Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00052910 - Recruiting
Esophageal Cancer; Gastric Cancer
- Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00511446 - Recruiting
Stomach Neoplasms
- A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00512681 - Recruiting
Stomach Neoplasms
- Study of S-1 Versus Capecitabine as First-Line Chemotherapy in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer
ClinicalTrials.gov Identifier: NCT00580359 - Recruiting
Stomach Neoplasms
- Perioperative Nutrition in Upper GI Cancer Surgery
ClinicalTrials.gov Identifier: NCT00560846 - Recruiting
Stomach Neoplasms; Esophageal Neoplasms; Surgical Complications
- Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer
ClinicalTrials.gov Identifier: NCT00017537 - Active, not recruiting
recurrent ovarian epithelial cancer; stage IV non-small cell lung cancer; unspecified adult solid tumor, protocol specific; ...
- Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00032123 - Completed
stage IV gastric cancer; stage IV esophageal cancer; adenocarcinoma of the stomach; Adenocarcinoma of the Esophagus; recurrent esophageal cancer; ...
- Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
ClinicalTrials.gov Identifier: NCT00003862 - Completed
stage I gastric cancer; stage II gastric cancer; stage III gastric cancer; stage IV gastric cancer; adenocarcinoma of the stomach
- Study of Sunitinib in Combination With Cisplatin/Capecitabine or Oxaliplatin/Capecitabine in Patients With Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00555620 - Not yet recruiting
Cancer of the Stomach
- Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction
ClinicalTrials.gov Identifier: NCT00080002 - Terminated
Cancer of Stomach; Gastroesophageal Cancer
- Study of Sunitinib With S-1 and Cisplatin for Gastric Cancer
ClinicalTrials.gov Identifier: NCT00553696 - Not yet recruiting
Stomach Neoplasms
- FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer
ClinicalTrials.gov Identifier: NCT00098527 - Suspended
adenocarcinoma of the stomach; recurrent gastric cancer; Adenocarcinoma of the Esophagus; recurrent esophageal cancer
- A Comparison of SmartPill Capsule with Scintigraphy for Determining Gastric Residence Time
ClinicalTrials.gov Identifier: NCT00128284 - Recruiting
Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases; Gastroparesis
- A Phase I Study of Sunitinib in Combination With Cisplatin and 5-Fluorouracil in Patients With Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT00555672 - Not yet recruiting
Stomach Neoplasms
- Pharmacogenetics of Gastrointestinal Bleeding
ClinicalTrials.gov Identifier: NCT00190255 - Active, not recruiting
Gastrointestinal Hemorrhage; Stomach Ulcer; Anti-Inflammatory Agents, Non-Steroidal
- Zinc Supplements in Lowering Cadmium Levels in Smokers
ClinicalTrials.gov Identifier: NCT00376987 - Active, not recruiting
Bladder Cancer; Cervical Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Kidney Cancer; Leukemia; Liver Cancer; Lung Cancer; Pancreatic Cancer; Tobacco Use Disorder
Resources
- American Cancer Society
- Angiogenesis Inhibitors (National Cancer Institute)
email this page
print this page
bookmark this page
feedback on this page
